
Product Details
53-39-4 Name |
|
Name |
Oxandrolone |
Synonym |
Oxandrin,17β-Hydroxy-17-methyl-2-oxa-5α-androstan-3-one,(5a,17b)-17-Hydroxy-17-methyl-2-oxaandrostan-3-one,oxandrolone,Vasorome,Lonavar,Anavar,Oxandrolonum,2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5α,17β)-,Ossandrolone,Provitar,2-Oxa-5α-androstan-3-one, 17β-hydroxy-17-methyl-,MFCD00198944 |
53-39-4 Chemical & Physical Properties |
|
Melting point |
235-238°C |
Boiling point |
444.4±45.0 °C at 760 mmHg |
Density |
1.1±0.1 g/cm3 |
Molecular Formula |
C19H30O3 |
Molecular Weight |
306.440 |
Flash Point |
179.1±21.5 °C |
PSA |
46.53000 |
LogP |
3.33 |
Exact Mass |
306.219482 |
Vapour Pressure |
0.0±2.4 mmHg at 25°C |
Index of Refraction |
1.526 |
53-39-4 Description |
Oxandrolone is a synthetic anabolic-androgenic steroid. It is a 17 alpha-methylated version of dihydrotestosterone (DHT). It can be used for the treatment of many kinds of disorders such as idiopathic short stature, body mass loss due to catabolic illness, severe burns, trauma and hereditary angioedema as well as turner syndrome. Oxandrolone is especially effective in the treatment of severe burns without causing obvious side effects. It acts as an agonist of the androgen receptor, which modulates related gene expression to increase protein synthesis, further boosting muscle growth and increasing body mass as well as bone mineral density. However, it should be noted that its androgenic effect is less than its anabolic effect. Oxandrolone, 17β-hydroxy-17-methyl-2-oxaandrostan-3-one, is approved to aid in the promotionof weight gain after weight loss following surgery,chronic infections, or severe trauma and to offset protein catabolismassociated with long-term corticosteroid use.Oxandrolone is also used to relieve bone pain accompanyingosteoporosis. It has been used to treat alcoholic hepatitisand HIV wasting syndrome. |
53-39-4 Uses |
The use of oxandrolone, an analog of testosterone possessing only 5% of testosterone's virilizing androgenic effects, enhances anabolism of muscle protein by improving the efficiency of protein synthesis in severely burned children. Oxandrolone administration decreases loss of body weight and improves healing of the donor site wound. In a large clinical trial by our group, 0.1 mg/kg oxandrolone administered twice daily reduced length of the acute hospitalization, sustained LBM, and improved liver protein synthesis. Severely burned pediatric patients receiving oxandrolone for 1 year experienced improved growth, decreased cardiac work, and improved muscle strength. Oxandrolone treatment also improved lung function at rest and during exercise in this patient population. These improvements were maintained for up to 4 years after treatment had ended. The benefits of oxandrolone administration after burn injury were further enhanced when the treatment period was increased from 1 to 2 years. |